Testing on humans of a novel COVID-19 vaccine developed in Brazil will begin this year. It performed well in animal trials, as reported in an article published in August in Nature Communications. The scientists responsible ...
Oct 6, 2022
0
10
The U.K. conducted world-leading COVID-19 research and was the first country to find a treatment that worked, so why did it also have such a high death rate?
Sep 27, 2022
0
14
France became the latest country on Tuesday to authorize new COVID-19 vaccines that have been updated to target Omicron subvariants ahead of autumn booster campaign.
Sep 20, 2022
0
9
A vaccine candidate called R21 has been shown to be up to 80% effective at preventing malaria in young children, according to the latest trial results.
Sep 15, 2022
0
6
When the mRNA COVID-19 vaccines were first unveiled in December 2020, medical experts touted the benefits of this new technology, saying formulations could easily be tweaked someday to match a quickly changing virus. That ...
Sep 15, 2022
0
6
The COVID-19 booster shots are well tolerated by both pregnant and nursing women, a new study published Sept. 8 in JAMA Network Open concluded.
Sep 13, 2022
0
49
Researchers from the University of Oxford and their partners have today reported new findings from their Phase 2b trial following the administration of a booster dose of the candidate malaria vaccine, R21/Matrix-M—which ...
Sep 11, 2022
0
5
The World Health Organization on Thursday said it is launching a $1.5 billion campaign, hopefully including a new vaccine, to eliminate outbreaks of bacterial meningitis across Africa by 2030.
Sep 8, 2022
0
14
The benefits of a new COVID-19 booster that targets omicron variants far outweigh the possible risks, experts say.
Aug 25, 2022
0
25
Pfizer Inc. said Monday that it has asked the U.S. Food and Drug Administration to approve the emergency use of an updated booster shot that targets several versions of the omicron variant.
Aug 23, 2022
0
5
